Path Robotics develop and advance state-of-the-art methods to solve general problems and apply what they develop to manufacturing. They think about how to make machines learn, adapt, and solve problems faster and more robustly.

Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.

AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology. The company was founded in 2016 and is headquartered in Chelmsford, Massachusetts.

To address the exploding demand for efficacious mental healthcare globally, Mobio Interactive has developed and commercialised an AI-powered digital theragnostic platform that delivers clinically validated psychotherapy programmes personalised to every patient using digital biomarkers that quantify human brain states without relying on a wearable.

Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.

Rhaeos, the world's first wearable shunt monitor, aims to improve the quality care for patients with hydrocephalus through a novel, thermal biosensor. Developed within Northwestern University with collaboration between Dr. John Rogers, McCormick School of Engineering, Feinberg School of Medicine and Kellogg School of Management, Rhaeos represents a unique multidisciplinary translational effort for an important clinical need.

Visolis, a bioengineering company, develops carbon-negative and sustainable chemicals. Its systems approach integrates innovations in synthetic biology, chemical catalysis, and process scale-up to enable new bio-based manufacturing platforms. Visolis' bio-based process helps in achieving true carbon negative chemical synthesis. It began operation in 2012, with its headquarters in Berkeley in California.

FORT Robotics makes wireless safety systems for dangerous machines. Formerly part of HRI, FORT is a VC-backed company built on more than a decade of experience in safety technology. FORT Robotics is building a first-of-its-kind safety and security platform for smart machines. FORT’s mission is to unlock the full potential of automation by accelerating development, reducing risk, and building trust in autonomous systems.

Circuit Mind builds Artificial Intelligence that completely automates the design of Electronics Circuit boards

VenoStent develops medical devices intended to enhance the quality and longevity of patients undergoing dialysis. The device of the company is made of a new class of shape-memory polymers used in coronary artery bypass surgery mainly as an external stent that requires no sutures, allowing physicians to reduce surgery time, risk of infection, and wound re-opening of patients with hemodialysis, while also reducing venous occlusion failure.

ALICE Technologies is the world's first AI-powered construction simulation platform. Founded in 2015 based on research from Stanford University, ALICE leverages artificial intelligence to analyze a project's complex building requirements, generate highly efficient building schedules, and tune those schedules as needed during construction. ALICE enables contractors and owners to plan, bid, and build more effectively, reducing construction times and labor costs by $30 million for a typical $500 million construction project. ALICE Technologies works with construction leaders in the infrastructure and commercial construction segments, such as Parsons, HDCC, and Kajima Corporation. Learn more at www.alicetechnologies.com.

PlanetWatchers is a SaaS solution for enterprises, governments and NGOs to monitor their natural assets across multiple sectors. Their geospatial technology combines advanced machine learning algorithms, elastic cloud infrastructure and multi-source satellite sensors to deliver a robust monitoring and alerting system, which provides critical information to advance the management of large-scale assets at global and regional scales.